BPA Call 36C25021A0051-36C25022N0271
- Roche Diagnostics Corporation received a $113,618.48 firm fixed-price delivery order from Veterans Integrated Service Network (VISN) 10 for HPV (human papillomavirus) testing equipment, supplies, and preventive maintenance services under Option Year 2. The contract was awarded on February 5, 2023, with an ultimate completion date of February 4, 2024, and is being performed in Castleton, Indiana. This award represents a child order under Roche's Critical Analyzers, Laboratory (FSS-66-III) General...
- Roche Diagnostics Corporation received a $77,704.92 firm fixed-price delivery order from Veterans Integrated Service Network 10, a civilian agency under the Department of Veterans Affairs, for HPV testing equipment, supplies, and preventive maintenance services under Option Year 1. The contract was awarded on February 5, 2021, with an ultimate completion date of February 4, 2022, and will be performed at Roche's facility in Castleton, Indiana. This award was made without a set-aside...
- Roche Diagnostics Corporation has been awarded a $126,006.07 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 10 for human papillomavirus (HPV) testing equipment, supplies, and preventive maintenance services. This is the fourth option year under a Blanket Purchase Agreement established on the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The order is scheduled for completion by July 4, 2026, with...
- Roche Diagnostics Corporation was awarded a firm fixed-price blanket purchase agreement call order valued at $84,142.60 for HPV testing equipment, supplies, and preventive maintenance services under Option Year 3. The award was made by Veterans Integrated Service Network 10, the civilian healthcare network serving veterans across a multi-state region, with performance taking place at Roche's facility in Castleton, Indiana. This delivery order represents a continuation of the parent BPA...
- Roche Diagnostics Corporation was awarded a $387,011.95 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to provide human papillomavirus (HPV) testing kits. The contract was awarded on October 1, 2019 under the Critical Analyzers, Laboratory GSA Schedule with performance required at a location in Castleton, Indiana by November 16, 2020. No set-aside designation was applied to...
- Roche Diagnostics Corporation was awarded a $409,522.65 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to deliver HPV test kits. The contract was issued against GSA Schedule 66-III for Critical Analyzers, Laboratory and has a period of performance through September 30, 2021. Place of performance will be in Castleton, Indiana. No set-aside designation was used for this contract...
- Roche Diagnostics Corporation received a $33,561.68 firm fixed-price delivery order from Veterans Integrated Service Network (VISN) 10, a component of the Department of Veterans Affairs, for Roche Diagnostic brand reagents and consumables supplies. The award, announced on March 1, 2026, is scheduled for completion by February 28, 2027, and will be performed at the contractor's facility in Castleton, Indiana. This is a competitive award with no set-aside designation, reflecting open competition...
- Roche Diagnostics Corporation has been awarded a $150.4K firm fixed-price Blanket Purchase Agreement (BPA) call for reagents and consumables to support human papillomavirus (HPV), chlamydia (CT), and neisseria gonorrhoeae (NG) testing. The contract, effective October 1, 2024, with an ultimate completion date of September 30, 2025, was awarded by Veterans Integrated Service Network 12 (a component of the Department of Veterans Affairs) with no set-aside designation. This award is a child contract...
- Roche Diagnostics Corporation was awarded a $124.9K firm fixed price call under a Blanket Purchase Agreement (BPA) on December 1, 2024, to supply reagents and consumables for HPV, chlamydia, and gonorrhea testing. This contract award is issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule and is funded by Veterans Integrated Service Network 12 (VISN 12), a component of the Department of Veterans Affairs. The work will be performed in Castleton,...
- Roche Diagnostics Corporation has been awarded a $349,993.61 firm fixed-price delivery order by Veterans Integrated Service Network 19 (VISN 19) for emergency one-year molecular virology testing services. This is a child contract issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule and will be performed in Oklahoma City, Oklahoma, with completion targeted for January 25, 2027. The award was made without a set-aside designation, indicating open...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797D70105-36C25021A0051Blanket Purchase Agreement
- 36C25021A0051-36C25022N0271BPA Call
Roche Diagnostics Corporation received a $54,442.32 firm fixed-price delivery order from Veterans Integrated Service Network 10 (VISN 10), a civilian component of the Department of Veterans Affairs, for HPV testing equipment, supplies, and preventive maintenance services. The award was issued on February 5, 2022, with an ultimate completion date of February 4, 2023, and represents a call against an existing Blanket Purchase Agreement established under the General Services Administration's Critical Analyzers, Laboratory Schedule (FSS-66-III). The contract was not set-aside for small business concerns and will be performed at Roche's facility in Castleton, Indiana. This delivery order is consistent with VISN 10's broader relationship with Roche Diagnostics, which includes a $2.0 million BPA for COBAS 6800 molecular testing services and maintenance extending through December 2030. As a leading supplier of in vitro diagnostic solutions to the Department of Veterans Affairs and other federal healthcare agencies, Roche Diagnostics routinely provides laboratory analyzers, reagents, and consumables to support clinical diagnostic testing across the VA system. The HPV testing equipment and supplies delivered under this order would support cervical cancer screening and prevention initiatives at VISN 10 facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($72k) | 2/15/23 | |
| Not listed | Not listed | $126.0k | 1/12/22 |